HeartBeam Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership Transition

HeartBeam announced a strategic pivot to license its 3D ECG technology to partners rather than pursuing direct medical device sales, aiming to accelerate global adoption with a leaner cost structure. The reorganization includes a leadership transition where CEO Robert Eno moves to a consulting role, with operations now led by Founder Branislav Vajdic and Executive Chairman Rich Ferrari.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.